# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 142: Amendment to Schedule 24

Extent: E+W+S+N.I.

In Schedule 24 (packaging information requirements)—
(a) in paragraph 7(b), omit the words from “in the case of products for sale or supply in Great Britain” to the end;
(b) in paragraph 15, omit “EU marketing authorisation”;
(c) in paragraph 16, omit “EU marketing authorisation”;
(d) omit paragraph 18A;
(e) at the end of Part 1, insert—
“18B. The words “UK only”.”;
(f) in paragraph 23, omit “EU marketing authorisation”;
(g) in the heading to Part 4, omit “for sale or supply in Great Britain only”;
(h) in the heading to Part 5, omit “for sale or supply in Great Britain only”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/142 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-142
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.